Core Viewpoint - Broadwood Partners and its affiliates announced that Egan-Jones Ratings Company has reaffirmed its recommendation for shareholders to vote "AGAINST" the proposed acquisition of STAAR Surgical Company by Alcon Inc. [1] Group 1 - Egan-Jones Ratings Company is a leading proxy advisory firm [1] - The recommendation is to vote against the acquisition on the GREEN Proxy Card [1] - The announcement follows STAAR's completion of a 30-day go-shop period [1]

国内干眼药物治疗领域正在加速变革。 干眼新机制药物初露头角 长期以来，传统干眼药物多聚焦于缓解症状，以玻璃酸钠滴眼液为代表的人工泪液是主流产品。在医药电商平台的干眼用药销售排行榜上，前十位产品绝 大多数为玻璃酸钠滴眼液。 在国内眼科市场，一批已上市干眼新药开始崭露头角，填补传统治疗的空白。 这些新机制药物凭借从源头解决干眼问题的临床价值，已初步获得市场认可，一组销售数据可以佐证。 2025年，恒瑞医药用于干眼的"恒沁"全氟己基辛烷滴眼液上市，电商平台零售价468元/盒，在京东大药房上线3个多月（1盒装）销量达到5000+，并跻 身"眼干涩"用药排行榜第8。2024年底，远大医药引进的酒石酸伐尼克兰鼻喷雾剂在国内获批上市，零售价599元/支，2025年上半年成为远大医药五官科 收入增长的动力之一。 与传统干眼药物相比，这些基于新机制的干眼药物价格高出几倍甚至十倍，仍实现了上市即热销。这是否意味着，干眼药物市场的竞争逻辑与发展格局或 将发生变革？ 睑板腺功能障碍（MGD）是睑板腺的慢性、非特异性炎症，以睑板腺导管的阻塞或睑板腺分泌物异常为特征，是蒸发过强型干眼的主要原因。有临床研 究显示，69%—86%的干眼人群 ...

Core Insights - Galderma's market capitalization has exceeded 35 billion Swiss francs (approximately 310 billion RMB) as of November 2025, reflecting significant growth since its IPO in March 2024 [1][2] - The company has demonstrated strong financial performance, with a sales revenue of 1.289 billion USD (approximately 9.2 billion RMB) in Q3 2025, marking a 21% year-on-year increase [4] - Galderma has raised its full-year revenue growth guidance for 2025 to 17.0%-17.7%, up from the previous estimate of 12%-14% [4] Company Background - Galderma originated from the American Owen Laboratory, founded in 1961, and has undergone several ownership changes, including acquisitions by Alcon and Nestlé [5][6][10] - The company was established as a joint venture between Nestlé and L'Oréal in 1981, focusing on dermatological research [7] - In 2019, Nestlé sold its stake in Galderma, which then became an independent entity, emphasizing skincare and aesthetic medicine [10] Product Portfolio - Galderma's product range includes brands such as Restylane, Dysport, and Cetaphil, covering aesthetic injectables, skincare, and dermatological treatments [11][13] - The company has a robust pipeline with over 40 years of research experience, five R&D centers, and 55 patents [10][20] Financial Performance - In the first nine months of 2025, Galderma's three main business segments—injectable aesthetics, daily skincare, and dermatological treatments—showed overall growth [18] - The injectable aesthetics segment generated 1.871 billion USD (approximately 13.325 billion RMB) in sales, with a 10.5% year-on-year increase [15] - The dermatological treatment segment saw a remarkable 40.4% increase in sales, reaching 804 million USD (approximately 5.726 billion RMB) [16] Strategic Insights - Galderma's success is attributed to its long-term commitment to R&D, establishing a competitive edge in the skincare industry [20] - The company employs a "pyramid" product strategy, balancing stable cash flow from daily skincare with high-growth and high-margin aesthetic injectables [21][23] - Galderma's global presence in over 100 countries is complemented by localized strategies that cater to specific market preferences [25][26] Industry Implications - The medical aesthetics industry is shifting from marketing-driven approaches to product and R&D-focused strategies, with Galderma serving as a model for other companies [19] - Establishing "professional trust" through clinical partnerships and scientific evidence is becoming increasingly important in a market saturated with low-level marketing [28]

Core Points - The U.S. and Switzerland have reached a trade agreement to lower tariffs on Swiss goods from 39% to 15% [1] - Switzerland is committed to investing $200 billion in the U.S. during Trump's second presidency, including $70 billion next year [2] - The total goods trade between the U.S. and Switzerland was estimated at $88.4 billion in 2024, with Swiss watch exports to the U.S. growing significantly [4] Trade Agreement Details - The agreement aims to reduce tariffs on luxury exports from Switzerland, which include jewelry, coffee, and chocolate [1] - U.S. trade representative Jamieson Greer indicated that the agreement is "essentially" finalized [1][3] Investment Commitments - Switzerland plans to invest heavily in U.S. sectors such as pharmaceuticals and gold smelting, with Roche pledging $50 billion [2] - The commitment includes purchasing more Boeing commercial planes [2] Impact on Goods Trade - Swiss exports to the U.S. have been growing at a rate of 14% annually since 2019, significantly outpacing the global average [4] - Swiss watch exports surged 18.2% overall, with shipments to the U.S. increasing by 149% following the announcement of tariffs [4]

Group 1: General Motors (GM) - General Motors has directed thousands of its suppliers to remove components sourced from China, aiming for a complete relocation away from China by 2027 [5] - The initiative began in late 2024 and is accelerating due to rising tensions between the U.S. and China, with GM preferring to source parts from North American factories but open to suppliers outside the U.S. as long as they exclude China [6] - The transition is challenging as many parts GM relies on, such as lighting, electronics, and battery materials, are dominated by China [7] Group 2: Advanced Micro Devices (AMD) - AMD's CEO updated the total addressable market for AI data centers, projecting it to reach $1 trillion by 2030, up from a previous estimate of $500 billion [8] - The CEO emphasized that the pace of change in AI is unprecedented, with companies expressing a strong need to invest in AI infrastructure, indicating insatiable demand [9] - AMD's gross margins are expected to range between 55% and 58%, which is better than previously forecasted [10] Group 3: Alphabet (Google) - Google is facing a lawsuit accusing it of using its Gemini AI assistant to unlawfully track private communications of Gmail users and others [10] - The lawsuit claims that Google secretly activated Gemini for all applications in October, allowing it to collect private data without user consent [11] - Users can deactivate Gemini, but they must navigate through Google's privacy settings to do so, otherwise, Google can access the entire recorded history of users' private communications [12]

Group 1: General Motors (GM) - General Motors has directed thousands of its suppliers to remove components sourced from China, targeting a complete relocation away from China by 2027 [5] - The initiative began in late 2024 and is accelerating due to rising tensions between the U.S. and China, with GM preferring to source parts from North American factories but open to suppliers outside the U.S. as long as they exclude China [6] - The transition is challenging as many parts GM relies on, such as lighting, electronics, and battery materials, are still dominated by China [7] Group 2: Advanced Micro Devices (AMD) - AMD's CEO updated the total addressable market for AI data centers, projecting it to reach $1 trillion by 2030, up from a previous estimate of $500 billion [8] - The CEO emphasized that the pace of change in AI is unprecedented, with companies expressing a strong need to invest in AI infrastructure, indicating insatiable demand [9] - AMD's gross margins are expected to range between 55% and 58%, which is better than previously forecasted [10] Group 3: Alphabet (Google) - Google is facing a lawsuit accusing it of using its Gemini AI assistant to unlawfully track private communications of Gmail users and others [10] - The lawsuit claims that Google "secretly" activated Gemini for all applications in October, allowing it to collect private data without user consent [11] - Users can deactivate Gemini, but they must navigate through Google's privacy settings to do so, otherwise, Google can access the entire recorded history of users' private communications [12]

Market Overview - U.S. stock futures rose on Wednesday following a mixed close on Tuesday, with major benchmark indices showing positive movement [1] - Investors are anticipating a House vote on a temporary spending bill aimed at ending the prolonged government shutdown [1] - The 10-year Treasury bond yielded 4.08%, while the two-year bond was at 3.56%, with a 63.4% likelihood of the Federal Reserve cutting interest rates in December [1] Futures Performance - Dow Jones increased by 0.17%, S&P 500 by 0.40%, Nasdaq 100 by 0.71%, and Russell 2000 by 0.19% [2] - SPDR S&P 500 ETF Trust (SPY) rose 0.37% to $685.55, and Invesco QQQ Trust ETF (QQQ) advanced 0.68% to $625.79 in premarket trading [2] Stocks in Focus - Cisco Systems Inc. (CSCO) is expected to report quarterly earnings of 98 cents per share on revenue of $14.77 billion, with a premarket increase of 0.49% [6] - Advanced Micro Devices Inc. (AMD) surged 5.13% in premarket trading following a positive analyst day, projecting strong growth in the AI chip and data center industry [6] - BILL Holdings Inc. (BILL) saw a significant increase of 13.12% after reports of a potential sale, maintaining a strong short and medium-term price trend [6] Sector Insights - TotalEnergies SE (TTE) rose 0.72% after signing a 15-year agreement with Alphabet Inc. to supply 1.5 terawatt hours of renewable electricity from its Ohio solar farm [5][7] - Alcon AG (ALC) gained 5.42% after reporting optimistic third-quarter results, projecting FY25 earnings of $3.05 to $3.15 per share on sales of $10.3 billion to $10.4 billion [14] Economic Insights - LPL Financial identifies AI infrastructure as a new pillar of economic growth, with significant investments from tech giants contributing to U.S. economic expansion [11] - There is potential for further expansion in AI-related capital spending, supported by strong loan demand from large firms [12] - LPL's Strategic and Tactical Asset Allocation Committee maintains a neutral stance on equities, noting the potential for volatility due to high optimism in current valuations [12][13]

Market Overview - U.S. stock futures rose on Wednesday following a mixed close on Tuesday, with major benchmark indices showing positive movement [1] - Investors are anticipating a House vote on a temporary spending bill aimed at ending the prolonged government shutdown [1] - The 10-year Treasury bond yielded 4.08%, while the two-year bond was at 3.56%, with a 63.4% likelihood of the Federal Reserve cutting interest rates in December [1] Futures Performance - Dow Jones increased by 0.17%, S&P 500 by 0.40%, Nasdaq 100 by 0.71%, and Russell 2000 by 0.19% [2] - SPDR S&P 500 ETF Trust (SPY) rose 0.37% to $685.55, and Invesco QQQ Trust ETF (QQQ) advanced 0.68% to $625.79 in premarket trading [2] Stocks in Focus - Cisco Systems Inc. (CSCO) was up 0.49% in premarket, with analysts expecting quarterly earnings of $0.98 per share on revenue of $14.77 billion [6] - Advanced Micro Devices Inc. (AMD) surged 5.13% after a positive analyst day, projecting strong growth in the AI chip and data center industry [6] - BILL Holdings Inc. (BILL) experienced a significant increase of 13.12% following reports of a potential sale, despite a weaker long-term price trend [6] Company Agreements - TotalEnergies SE (TTE) rose 0.72% after signing a 15-year agreement with Alphabet Inc. to supply 1.5 terawatt hours of renewable electricity from its Ohio solar farm [5][7] Sector Performance - Health care, energy, and consumer staples sectors gained on Tuesday, while information technology stocks closed lower [9] Economic Insights - LPL Financial identified AI infrastructure as a new pillar of economic growth, with significant investments from major tech firms contributing to economic expansion [11] - There is potential for further expansion in AI-related capital spending, supported by strong loan demand from large firms [12] - LPL remains cautious about concentration risk in the market, favoring growth over value and large caps over small caps [13]

Group 1 - Alcon's stock rose by 5.5% in pre-market trading, reaching $81.65 [1] - The company's Q3 core earnings per share were $0.79, slightly down from $0.81 a year ago [1] - Alcon reported quarterly net sales of $2.59 billion, an increase from $2.43 billion in the previous year [1] Group 2 - The company reaffirmed its full-year core earnings guidance for 2025, projecting $3.05 to $3.15 per share [1] - Alcon maintained its 2025 net sales guidance in the range of $10.3 billion to $10.4 billion [1]

Group 1 - European stocks are expected to open broadly higher, driven by optimism regarding the potential end of the U.S. government shutdown [1] - The U.K.'s FTSE index is projected to remain unchanged, while Germany's DAX, France's CAC 40, and Italy's FTSE MIB are expected to rise by 0.4%, 0.25%, and 0.22% respectively [2] - Earnings reports are anticipated from several companies including Infineon Technologies, E.ON, Experian, Alcon, RWE, Bayer, Swiss Life, Poste Italiane, SSE, and ABN Amro [2] Group 2 - SoftBank Group shares experienced a decline of up to 10% after the announcement of the sale of its entire stake in Nvidia for $5.83 billion [2] - The sale involved 32.1 million Nvidia shares, contributing to a total of $9.17 billion raised by SoftBank through the trimming of its T-Mobile position [3] - There are ongoing discussions about a potential stock market bubble, with investors becoming more selective regarding which tech companies are leading in the AI sector [4]